EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 18, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.2370?guestAccessKey=4e1a1467-cfc9-4414-83f2-3f4ab9529322&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061820
What The Viewpoint Says: The challenges associated with conducting and assessing results of clinical trials during the COVID-19 pandemic are discussed in this Viewpoint.
Authors: Chaya S. Moskowitz, Ph.D., of the Memorial Sloan Kettering Cancer Center in New York, is the corresponding author.
Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.